CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

On the Gender Gap in Radiology

Published: Mon, 19 Nov 2018 12:00:00 EST
Why is radiology failing to attract more women? This editorial explores how diversity might be improved in the radiology specialty.
Applied Radiology

VNS With Upper Limb Rehabilitation After Chronic Stroke

Published: Mon, 19 Nov 2018 12:00:00 EST
Is vagus nerve stimulation a useful adjunct to standard rehabilitation for improving arm function after chronic ischemic stroke?
Stroke

Influenza A(H3N2) Variant Virus Outbreak at Three Fairs

Published: Mon, 19 Nov 2018 12:00:00 EST
This report highlights the potential of variant influenza outbreaks associated with agricultural fair settings in the United States, especially after direct or indirect swine contact.
Morbidity & Mortality Weekly Report
Displaying results 7-9 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Arena bags big deal with United for PAH drug ralinepag

Published: Thu, 15 Nov 2018 13:52:44 +0000
Arena’s run of positive news continues, with a massive $800 million upfront licensing deal with United Therapeutics for its pulmonary arterial hypertension (PAH) drug ralinepag.

Dermavant hires Todd Zavodnick as CEO 

Published: Thu, 15 Nov 2018 11:24:49 +0000
Dermavant has named Todd Zavodnick as its CEO. The dermatology-focused Roivant subsidiary hired Zavodnick to fill a leadership space vacated by Jackie Fouse in September.

Could a combo of cancer drugs for adults also treat neuroblastoma in children?

Published: Thu, 15 Nov 2018 10:27:07 +0000
Scientists in Australia have early evidence that a combination of Novartis’ FDA-approved multiple myeloma therapy Farydak and an early-phase compound from Incuron holds potential for treating children with the nerve-tissue cancer neuroblastoma.
Displaying results 7-9 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top